volume 10, issue 3, Pe102-e106 2015
DOI: 10.1016/j.clnesp.2015.04.001
View full text
|
|
Share

Abstract: This study demonstrates that due to the significant gastrointestinal toxicity, EN was not feasible to commence when oral intake became inadequate. This study was registered with the Australian New Zealand Clinical Trials Registry (ANZCTR), Trial Number ACTRN12611001084976.